Robertet Leans Into Plant-based Biotechnologies

Core Insights - Robertet is investing in Aethera Biotech to enhance its capabilities in plant-based biotechnologies, with a joint venture planned to be 50-50 owned by both companies in the long term [1][2] Group 1: Investment Details - The investment in Aethera Biotech will occur in two phases over three years, contingent on undisclosed market conditions [1] - Financial terms of the deal have not been disclosed [1] Group 2: Company Background - Aethera Biotech, founded in 2016 and based in Camisano Vicentino, Italy, specializes in producing active ingredients for the cosmetic and health markets through cell multiplication processes [3] - Aethera is a subsidiary of Cereal Docks Group, which focuses on primary agro-food transformation [3] Group 3: Biotechnology Strategy - The partnership aims to develop advanced cosmetic active ingredients, reflecting a targeted biotech strategy [2] - Aethera's proprietary CROP platform allows for the secure production of natural extracts in controlled conditions, independent of external factors [4] Group 4: Environmental Impact - The CROP platform significantly reduces environmental impact and offers a sustainable alternative to traditional production methods, embodying the concept of 'Augmented Naturality' [5] - This collaboration enables Robertet to strengthen its biotechnology expertise and secure sustainable access to innovative natural ingredients [6] Group 5: Leadership and Future Outlook - The joint venture aligns with Robertet's ambition to reinforce its leadership in natural ingredients and explore new pathways for innovation and growth [7]